Management of Abdominal Pain in Acute Gastroenteritis Patients With Hyoscine Butylbromide

Last updated: January 3, 2022
Sponsor: Ankara City Hospital Bilkent
Overall Status: Completed

Phase

4

Condition

Gastroenteritis

Dysmenorrhea (Painful Periods)

Ulcerative Colitis (Pediatric)

Treatment

N/A

Clinical Study ID

NCT04682860
Çağdaş Yıldırım
  • Ages 18-65
  • All Genders

Study Summary

One of the most common complaints of admission to the emergency room is gastroenteritis. One of the most common complaints in acute gastroenteritis is abdominal pain. The aim of our study is to investigate whether hyoscine butylbromide used within the indication has an effect on abdominal pain due to acute gastroenteritis. The main purpose of our study is to reduce the pain of the patient at 30th and 60th minutes compared to 0th minute.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients with watery stools starting in the last 2 weeks and 3 times in 24 hours andabdominal pain

Exclusion

Exclusion Criteria:

  • Peritonitis
  • Hemodynamic instability
  • Pregnancy
  • Inability to give consent
  • Medication given in the emergency room before being included in the study
  • Taking pain medication within 4 hours
  • Diabetes Mellitus and other neuropathic diseases

Study Design

Total Participants: 50
Study Start date:
September 08, 2021
Estimated Completion Date:
January 03, 2022

Connect with a study center

  • Ankara City Hospital

    Ankara, 06100
    Turkey

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.